Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.
Company Details
- Employees
- 18
- Founded
- 2018
- Address
- 150 Cambridge Park Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Manager jobs.
- HQ
- Cambridge, Massachusetts
Exo Therapeutics Questions
Exo Therapeutics's LinkedIn profile is https://www.linkedin.com/company/exo-therapeutics
Exo Therapeutics has
18 employees.
View email and phone details for 18
employees at Exo Therapeutics.
Exo Therapeutics's industry is
Biotechnology Research
Exo Therapeutics's top competitors are
Relay Therapeutics,
Photys Therapeutics,
Nimbus Therapeutics,
Solu Therapeutics,
Pledge Therapeutics,
Moma Therapeutics,
Foghorn Therapeutics Inc.,
Beam Therapeutics,
Orthogon Therapeutics,
Kymera Therapeutics.
Exo Therapeutics's categories are Biotechnology Research
Exo Therapeutics's founding year is 2018
